Graph Therapeutics is improving the lives of patients with immune-mediated diseases through Al-driven precision medicine.
Investors 1
| Date | Name | Website |
| 02.02.2025 | SquareOne | squareone.... |
Mentions in press and media 2
| Date | Title | Description |
| 09.01.2025 | AI-powered drug discovery: Graph Therapeutics raises €3 million to tackle inflammatory diseases | Graph Therapeutics, a next-generation biotech company based in Vienna, announced today the closing of a €3 million pre-seed financing round to finance the development of an AI-powered platform to bring the precision medicine paradigm to inf... |
| - | Graph Therapeutics | “Graph Therapeutics” |